192 related articles for article (PubMed ID: 24458443)
1. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443
[TBL] [Abstract][Full Text] [Related]
2. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
Leufkens TR; Vermeeren A
J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
[TBL] [Abstract][Full Text] [Related]
3. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
Leufkens TR; Vermeeren A
Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
[TBL] [Abstract][Full Text] [Related]
4. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
5. On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.
Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
Psychopharmacology (Berl); 2014 Jul; 231(14):2851-65. PubMed ID: 24488406
[TBL] [Abstract][Full Text] [Related]
6. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
7. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
8. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
9. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
Vermeeren A; Riedel WJ; van Boxtel MP; Darwish M; Paty I; Patat A
Sleep; 2002 Mar; 25(2):224-31. PubMed ID: 11905433
[TBL] [Abstract][Full Text] [Related]
10. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
[TBL] [Abstract][Full Text] [Related]
11. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.
Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R
Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317
[TBL] [Abstract][Full Text] [Related]
12. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.
Sivertsen B; Omvik S; Pallesen S; Nordhus IH; Bjorvatn B
J Clin Sleep Med; 2009 Aug; 5(4):349-54. PubMed ID: 19968013
[TBL] [Abstract][Full Text] [Related]
13. Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers.
Iwamoto K; Iwata M; Kambe D; Imadera Y; Tachibana N; Kajiyama Y; Ando M; Ozaki N
Psychopharmacology (Berl); 2022 Mar; 239(3):841-850. PubMed ID: 35106620
[TBL] [Abstract][Full Text] [Related]
14. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
15. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control: Study Protocol Clinical Trial (SPIRIT Compliant).
Iwata M; Iwamoto K; Kambe D; Tachibana N; Ando M; Ozaki N
Medicine (Baltimore); 2020 Mar; 99(12):e19395. PubMed ID: 32195934
[TBL] [Abstract][Full Text] [Related]
17. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
18. Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades.
Bocca ML; Le Doze F; Etard O; Pottier M; L'Hoste J; Denise P
Psychopharmacology (Berl); 1999 Apr; 143(4):373-9. PubMed ID: 10367554
[TBL] [Abstract][Full Text] [Related]
19. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
20. Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials: NMA driving and hypnotics.
Fornaro M; Caiazza C; Rossano F; Cilmi F; De Prisco M; Vieta E; Thompson T; Solmi M; Carvalho AF; Iasevoli F; de Bartolomeis A
Eur Neuropsychopharmacol; 2024 Apr; 81():53-63. PubMed ID: 38401406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
